More
    Guided Solutions - Connecting Talent With Innovation/div>

    Funding

    Galvanize Therapeutics closes $100m Series C financing, hires new CEO

    Galvanize Therapeutics announced it raised $100 million and appointed Doug Godshall as chair and CEO. Godshall previously served as CEO of HeartWare before its $1...

    ViCentra raises $85m to drive insulin pump’s US market entry

    Dutch device company ViCentra has raised $85m to boost its Kaleido insulin patch pump’s entry onto the US market. According to the company, initial commercial...

    Berlin Heals Holding raises over $5m to advance heart failure treatment

    Berlin Heals Holding AG, a MedTech company, is developing a novel treatment to reverse remodel and recover from Heart Failure. After a successful First-In-Human...

    Cyted raises $44m to propel US market expansion of its endoscopic capsule

    UK-based Cyted Health has raised $44m to accelerate the ongoing market adoption of its EndoSign device in the US. The gastrointestinal (GI) diagnostic company’s EndoSign...

    SynCardia parent prices $17M IPO to support next-gen artificial heart

    Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced the pricing of a $17 million initial public offering (IPO). The Tucson, Arizona–based...

    Vaxxas raises $58.4M for needle-free vaccine delivery tech

    Vaxxas announced raised $58.4 million (A$90 million) in a new financing round supporting its vaccine delivery technology. The Brisbane, Australia-based company picked up about $32...

    Avasa raises $2.8m pre-Series A for micro-artery coupling device

    Avasa completed the first close of its pre-Series A fundraising round worth about $2.8 million (NZD$4.75 million). Movac, one of New Zealand’s largest and longest-standing...

    Twin Health secures $53m to accelerate AI Digital Twin for metabolic health

    Twin Health, a company focused on using AI digital twin technology for metabolic health, has announced a $53M investment led by Maj Invest of...

    ProVerum secures $80m Series B to advance nitinol stent for BPH

    ProVerum Limited, the developer of the ProVee System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced the closing of...
    1...101112...121Page 11 of 121

    Latest articles

    Popular articles

    Featured

    Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    © Copyright - Guided Solutions - Global Executive Search in Medical Devices